FDA Approves SKYTROFA® (Lonapegsomatropin-tcgd) for the Once-Weekly Treatment of Adults with Growth Hormone Deficiency
Source:
Nasdaq GlobeNewswire
/
28 Jul 2025 04:00:00 America/Los_Angeles
N/A
Share on,